
Innovator Capital's goal is to be recognised as a trusted, objective adviser able to assist the managements of growth companies to achieve their corporate goals; at all times keeping to the fore the relevant regulatory environments and the best interests of the company's shareholders.
We address the growing management needs for time, money, consistency and commitment essential to rapidly emerging companies. Typically companies have been offered standard advice and capital markets products by the traditional investment banks. Innovator will only represent the corporate party. This hugely reduces the possibility of conflict of interest and enables us to ensure that our clients receive advice which is in their best interests.
Most banks, who, by virtue of their business model, cannot fail to be conflicted or have to reach internal revenue targets by a certain date, have focused on clients that have larger market capitalisations to the relative exclusion of the smaller ones and some Bio-Medical and Environmental Technology companies have, as a result, been neglected or not given the best advice.
Innovator Capital’s intentionally adopted and Financial Services Authority registered virtual business model enables it to rapidly implement the services that are proposed and agreed to by the companies it works with. The services are extraordinarily beneficial to growth companies. It understands the time pressures that management are faced with and their need to feel secure that their shareholders best interests are considered to be of paramount importance. Innovator's approach creates a powershift in that CEOs and CFOs gain increased control over the process, timing and amount of their capital raisings and other corporate activities, recapturing some of the ground traditionally exploited by old style investment bankers.
Innovator's objective is to provide expert knowledge and intelligence of M&A opportunities and to give issuers superior guidance navigating the complexities of the financial markets. It advises CEOs and CFOs with respect to them having reliable and consistent access to primary and secondary share distribution at the correct price and where relevant, how best to build and maintain price momentum while optimising the daily trading volume of their shares.
The knowledge and experience Innovator Capital provides to its clients is based on Mungo's 30 years experience of investment banking in the US and Europe. During this time he focused on emerging and disruptive technologies in industries such as IT, Media, Telecoms, Industrial, Environmental and all areas related to Biotechnology, Pharmaceutical and Medicine.
Mungo has knowledge and experience of all major financial centres in the world and their capital markets.
He began his career at Prudential Bache before moving to America in the late seventies to join Alex. Brown & Sons, now part of Deutsche Bank. Following this, he was with Dillon Reid, Wertheim and Cowen & Co.
Mungo has been involved in the initial public offerings and subsequent offerings of well over a hundred companies, most notably Genentech, Amgen and Biogen. Today, these companies are international leaders in their sector.
In terms of experience Mungo has been involved in each of the core investment banking disciplines: origination, principal investing, trading, distribution and research in both the private and public equity markets. Additionally he has transaction experience in bridge financing, financial royalty structures, licensing and equity linked securities.
Mungo also brings industry experience to Innovator Capital's credentials having worked alongside Bernard Taylor (former Chief Executive of GSK).
Later, he was Head of Corporate Finance at Nomura International, where he founded Europe's leading investment banking practice for the emerging technology sector. Whilst at Nomura, Mungo and his team of over 60 professionals originated and successfully executed transactions in Europe, North America, the Middle East and Japan.
Innovator Capital, draws on Mungo's experience and flexibility to develop partnerships with select companies in the life sciences and environmental technology sectors. The firm employs ethical and regulatory sensitive business models developed by Mungo to enable more effective business partnerships.
Mungo has a compelling vision of how to guide a company along its development path and through to global leadership.
Contact Mr Mungo Park at: info@innovator-capital.com
Cynthia comes to Innovator Capital with a consultant background and many years of clean technology and environmental experience.
Cindy's passion for green companies started during her studies at UC Berkeley and quickly expanded to her involvement in the launch of Gaia Napa Valley – one of the nation's first completely sustainable spa hotels – her leadership in organising INSEAD's now annual Green Conference – a gathering of European technology, energy, private equity and venture capital firms – and her advisory positions with various European and American clean technology entrepreneurs.
Arran joins Innovator as Director of Cleantech Projects; his main focus is to advise in this area and match first class Solar and Wind projects with the appropriate investors. He has an architectural and technical background combined with extensive experience as an executive consultant in sustainability and renewable energy around the world.
Arran is uniquely positioned to deliver technical, financial and high level know-how and contacts within Renewable Energy and the Built Environment.
He has more than 20 years corporate commercial experience in the animal health, veterinary/food diagnostic, pharmaceutical and biotechnology industries. He has marketed, internationally, complex veterinary, medical and other life science products and services to business customers. Ashley, previously worked for large multinational organizations. In recent years, he has been instrumental in the establishment of eight start-up emerging technology companies, five of which he lead as CEO. Ashley's corporate experience encompasses general management, administration, corporate finance, business development (in/out-licensing) M&A and sales and marketing. He has provided investment advice/commercial due diligence to venture capital firms and advised start up companies seeking funding, as an advisor and as a non-executive director.
Ashley has raised over $100m of private equity funding, is involved in all Innovator Capital's corporate finance projects and is responsible for our licensing and M&A activities.
Jade obtained her degree from Edinburgh University in Modern Languages (French and Spanish) and then taught English in Buenos Aires.
Jade worked at Merrill Lynch Paris, in the Private Wealth Management department before joining the environmental team at Innovator Capital in August 2008. Jade is responsible for all aspects of the organisation of CleanEquity Monaco, the global annual emerging environmental technology conference; as well as being an integral part of our communications team helping to raise the profile of our clients. Jade has recently been awarded the Securities & Investment Institute Level 3 in Certificate in Corporate Finance and is FSA authorised.
Rebecca-Anne joined Innovator Capital as Executive Assistant to our Chairman. She has extensive senior level experience gained over a number of years and specialises in providing seamless support. Rebecca-Anne is accomplished in designing, implementing and maintaining functional administrative and organisational systems.
Rebecca-Anne brings with her a wealth of knowledge from within a varied sector background
Innovator Capital Limited is regulated by the Finacial Services Authority. www.fsa.gov.uk © Copyright 2008 Innovator Capital Limited. l T: +44 20 7297 6840 l E: info@innovator-capital.com